Build trust with your patient population by providing individual trial results
Easily implement this communication with a study-specific template.
Participants want personalized information.
A CISCRP survey showed that patients were interested in receiving a summary of their individual trial results (68%) and knowing if they had been given a placebo (52%)1.
of participants want to know their individual trial results
Fulfill another critically unmet ethical imperative by letting each trial participant know of their treatment assignment(s) once the trial is completed.
Develop a study-specific template or a globally applicable standardized approach that enables study teams to easily implement this communication and build trust with your patient population.
- 2019 CISCRP P&I Study, n=3,654 | Base: Those who have participated in a clinical trial